By using this website, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our
Privacy Policy
for more information.
Preferences
Deny
Accept
Attend
Read
Watch
Listen
About Us
Work with Us
Events
Contact
Weekly Digest
Job Board
synbiobeta 2021
live
OCTOBER 4 - 6
May 23-25
Oakland Marriott, California
Register Now
Because Being In The Same Room Is Better Than Being On The Same Zoom!
@ the Oakland Marriott City Center, Oakland CA
Back
Contact
What Is Synthetic Biology?
About BWB
Our Staff
Our Writers
Back
Contact
Advertise
Sponsors
Exhibitors
Conflict of Interest
Back
Contact
Job Board
Back
Contact
Current Event
Conferences
Courses
Industry Tours
Attend
Read
Watch
Listen
About Us
Stay Informed.
Sign-up for the SynBioBeta Weekly Digest and stay on top of all the industry news.
Thank you!
We'd love to ask a few more questions to better customize your experience.
Oops! Something went wrong while submitting the form.
Thank You!
We'd love to get to know you just a bit more.
Take a few minutes to personalize your content.
What is the size of your company?
1-10
11-100
101-500
501-5000
5000+
Synbio Stack?
Select one...
Industry Applications
Organism Engineering Platform
Automation / Software
Supply Chain
R&D Services
N/A
Synbio Stack?
Select one...
Industry Applications
Organism Engineering Platform
Automation / Software
Supply Chain
R&D Services
N/A
BACK
NEXT
Thank you!
You are now subscribed.
Oops! Something went wrong while submitting the form.
Weekly Digest
Site Search
Close
Become a Member
Insider
Free
Access to Premium Articles
Pick your content preferences
Industry Insider Newsletter
Invitation to Panel
Signup
Insider Premium
$3/month
Access to Premium Articles
Pick your content preferences
Industry Insider Newsletter
Invitation to Panel
Signup
Read
Click Here to Subscribe to Our Weekly Digest
OUR LATEST DIGESTS
June 1, 2023
Bespoke Disease Model Cells, Air-Purifying Plants, and Other Things You May Have Missed at SynBioBeta 2023
Sponsored by:
May 25, 2023
SynBioBeta Day 3 Ends On ‘Awesome’ Note
Sponsored by:
May 24, 2023
Day 2 at SynBioBeta Was Amazing! Strap in Cause It’s Not Over Yet
Sponsored by:
See More Digests »
SYNBIOBETA
SPOTLIGHTS
Lumen Bio
The human immune system is very good at recognizing foreign proteins. While this is critical for protecting against infections, it is sometimes too good: protein therapeutics like monoclonal antibodies are typically much safer than small molecule drugs, but the body often rejects them as foreign. Meet Lumen Bioscience, an antibody engineering company delivering therapeutics to places where our bodies won’t reject them: the GI tract, nasal passages, and skin. Our immune system is accustomed to all the foreign proteins we eat, smell, and touch, so this improves safety. These antibody drugs can be delivered in higher concentrations which improves efficacy against certain diseases. Learn more about Lumen’s promising clinical trial results and how they can produce antibodies at one-hundredth of the cost!
Cambrium
Consider the origins of the products we use in our daily lives; almost everything owes its history to the oil field, the strip mine or the slaughterhouse. Meet Cambrium, a Berlin-based synthetic biology company rethinking the material world by designing sustainable, high-impact proteins and producing them with microbes! By engineering the amino acid sequence in structural proteins, the company creates novel materials with specific properties and functions. Starting with optimized collagen for cosmetics, Cambrium is building a pipeline of highly functional, animal-free, fossil-free ingredients to usher in a new materials future without compromise. Learn more about Cambrium’s first product launch and stay tuned for news of the company’s upcoming collaborations with innovators in skincare and beyond!
SQIM
It’s no secret that animal agriculture is severely damaging our planet. While we transition our diets to sustainable proteins, we also need to reimagine our materials, especially leather. Meet SQIM, a materials company bringing plastic-free "mycelium leather" to market! By leveraging liquid and solid-state fermentation, SQIM is quickly scaling the production of EPHEA, a novel class of superior materials that can be thoroughly customized for use in the fashion industry. EPHEA can be dyed, embossed, finished, and adapted to create animal-free, high-quality products, without harming our planet. Learn more about SQIM, the ongoing scale-up of EPHEA, and their commercially available mycelium-based products for interior design, MOGU! (image: EPHEA)
LUCA
Women’s health has been long overlooked and underserved. Non-prescription supplements often claim to help women’s vaginal microbiome health, but none of them have proven therapeutic value. Meet LUCA Biologics, a biotechnology company developing a new class of microbe-based therapies to treat unmet needs in women's health. The company’s living medicines, which target the vaginal microbiome for urogenital and reproductive health, will go through a full FDA approval process and could finally offer women solutions for antibiotic-resistant UTIs, STIs, bacterial vaginosis and preterm birth. LUCA is also working to support women’s health globally, not only in affluent regions. Learn more about LUCA’s goals of supporting women and keep up with their clinical trial progress!
Molecular Devices & IDT
Collaboration, collaboration, collaboration: that’s the name of the synbio game and that’s why Molecular Devices and IDT are teaming up to make it easier for biotech companies to accelerate their research. For 35 years, IDT has supplied DNA constructs that are critical for research and discovery. Molecular Devices focuses on automated hardware and software for upstream and downstream processing and the robotics needed to screen up to 30,000 DNA clones every day. The companies’ synergy is clear: IDT supplies custom DNA and Molecular Devices provides the tools to efficiently run experiments and analyze the results. Now the companies are taking their synergy a step further. Learn more about IDT and Molecular Devices’ 2022 special offer to accelerate companies operating in the bioeconomy!
Roswell Biotechnologies
Most people wait to feel sick before they go to the doctor. But imagine if you could wake up in the morning, do a quick scan of your health using a semiconductor chip and immediately know your health status before symptoms even start. This kind of technology could democratize healthcare and ensure everyone can access their health information quickly and reliably. Meet Roswell Biotechnologies, a company turning individual molecules into biosensors on a chip. By miniaturizing biosensors, Roswell is able to fully leverage the power of chip technology to create scalable, affordable data snapshots about our health and our environment. Learn more about how Roswell is deploying their technology in drug discovery, biosecurity, crop protection, and much more!
See More Spotlights »
INDUSTRY NEWS
Filter by Category
Policy & Public
Food & Nutrition
Entrepreneurship
Energy & Environment
Emerging Technologies
Consumer Goods
Biomanufacturing, Chemicals & Materials
Funding & Investments
Health & Medicine
Agriculture
Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Policy & Public
Food & Nutrition
Entrepreneurship
Energy & Environment
Emerging Technologies
Consumer Goods
Biomanufacturing, Chemicals & Materials
Funding & Investments
Health & Medicine
Agriculture
How Scientists Are Trying to Engineer Artificial Cells to Move
June 2, 2023
How Scientists Are Trying to Engineer Artificial Cells to Move
June 2, 2023
Reichman University Ignites Innovation: The Scojen Institute for Synthetic Biology
June 2, 2023
SNIPR Biome's data on first clinical drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology
May 24, 2023
Cultivarium Announces Collaboration with ATCC to Expand Repertoire of Microbes Available for the Bioeconomy
May 24, 2023
Ayana Bio Launches First Plant Cell-Derived Health and Wellness Ingredients
May 24, 2023
Enveda Biosciences Announces Oversubscribed Series B1 Bringing Total Round to US$119 Million
May 24, 2023
Twist Bioscience Launches TCR and CAR Libraries to Enable the Development of Cell Therapies
May 24, 2023
HelloBiome Partners with K18, Inc. to Bring Microbiome Innovation to Hair Care
May 24, 2023
Logomix Inc. Starts Joint Research of Sustainable Amino Acid Production Method with Ajinomoto Co., Inc.
May 24, 2023
Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology
May 24, 2023
Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
May 24, 2023
Cemvita Promotes Co-founder Tara Karimi to CSO, Appoints New CTO Liz Dennett
May 24, 2023
Opinion: Synbio and AI combine for a more cohesive approach to drug discovery
May 24, 2023
Looking Ahead: The Human Health Investment Landscape
May 24, 2023
Aanika Biosciences is partnering with Greenlight Re Innovations
May 24, 2023
Cambrium Launches NovaColl™: First Micro-Molecular & Skin-Identical Collagen Ingredient for Personal Care Industry
May 24, 2023
Arzeda, the Protein Design Company™, Announces Collaboration with Takeda to Accelerate Protein Biologics Optimization
May 24, 2023
TeselaGen Offers its Starter Edition to Help BioTech Startups Scale Efficiently
May 24, 2023
Ginkgo Bioworks Supports the BioBuilder Educational Foundation's Boston Learning Lab
May 24, 2023
Synlogic Announces Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
May 24, 2023
See More Articles »